Biotech Investor Adds Million as Krystal Biotech Revenue Rises
A major biotech investor is stepping up its bet on Krystal Biotech as the company posts robust 2025 revenue. This mov...
Timing matters: automatic rebalancing should occur as your allocations drift beyond set thresholds.
18,157 articlesA major biotech investor is stepping up its bet on Krystal Biotech as the company posts robust 2025 revenue. This mov...
As markets digest a high-stakes political address and evolving risk appetite, bitcoin nudges higher. Traders balance ...
Salesforce just delivered a solid quarter with revenue and adjusted earnings topping expectations and a $50 billion b...
Investors chasing reliable profits often look for markets with strong rent demand and balanced growth. This article b...
NuScale Power stock has been under pressure as investors digest macro concerns and regulatory headwinds. This guide b...
Apple’s latest product lineup signals more than new gadgets—it signals a large-scale AI strategy. This article breaks...
Prediction markets are pricing a surprisingly small cost for a big Bitcoin bet. This article explains what traders pa...
G-III Apparel faced a sharp slide after its latest earnings, signaling investor caution about licensing-heavy fashion...
Ready to turn rent payments into an asset? This 7-step guide shows you how to buy your first rental property, with cl...
JAUST launches a cloud-native automated underwriting platform designed for jumbo mortgage originations, aiming to cut...
One transportation stock could outpace the S&P 500 in 2026 thanks to rising freight volumes, pricing power, and stron...
Investors are increasingly adding blue-chip art to mainstream portfolios to diversify beyond stocks and bonds. Fracti...